Assignee
DEV CT BIOTECHNOLOGY
TW·53 granted patents·18 pending applications·403 citations·filing 1990–2025
Top patents by PatentIndex Score
71 records- 0190US5250082AEncapsulated structure for plant initiate materialDEV CT BIOTECHNOLOGY·Filed 1992·Granted Oct 5, 1993·62 cites·11 claims
- 0281US9428575B2Anti-granulysin antibodies and methods of use thereofDEV CT BIOTECHNOLOGY·Filed 2013·Granted Aug 30, 2016·5 cites·13 claims
- 0380US11085062B2Processes for preparing glycoprotein-drug conjugatesDEV CT BIOTECHNOLOGY·Filed 2017·Granted Aug 10, 2021·2 cites·36 claims
- 0479US12091454B2Humanized anti-human neurotensin receptor 1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2022·Granted Sep 17, 2024·1 cites·19 claims
- 0579US5629202AComputer-controlled bioreactor system for enzymatic synthesis of L-tryptophanDEV CT BIOTECHNOLOGY·Filed 1995·Granted May 13, 1997·38 cites·13 claims
- 0677US10947316B2Antibody-drug conjugates containing anti-Globo H antibodies and uses thereofDEV CT BIOTECHNOLOGY·Filed 2018·Granted Mar 16, 2021·2 cites·12 claims
- 0774US10781266B2Antibodies specific to alpha-enolase and uses thereofDEV CT BIOTECHNOLOGY·Filed 2018·Granted Sep 22, 2020·1 cites·10 claims
- 0871US9527922B2Humanized alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CT BIOTECHNOLOGY·Filed 2014·Granted Dec 27, 2016·2 cites·15 claims
- 0970US5889051AStabilization of prostaglandin drugDEV CT BIOTECHNOLOGY·Filed 1997·Granted Mar 30, 1999·46 cites·24 claims
- 1067US5756516A1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical composition thereofDEV CT BIOTECHNOLOGY·Filed 1996·Granted May 26, 1998·18 cites·11 claims
- 1167US2025136709A1Anti-cd73 antibodies and use thereofDEV CT BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 1266US5091089AMicrobial decolorization of wastewaterDEV CT BIOTECHNOLOGY·Filed 1990·Granted Feb 25, 1992·36 cites·20 claims
- 1365US5710280APreparation of fluconazole and pharmaceutically acceptable salts thereofDEV CT BIOTECHNOLOGY·Filed 1996·Granted Jan 20, 1998·14 cites·20 claims
- 1465US5283066AMethod of stimulating an immune response by using a haptenDEV CT BIOTECHNOLOGY·Filed 1992·Granted Feb 1, 1994·34 cites·20 claims
- 1563US9750804B2Alpha-enolase specific antibodies and method of use in immune diseasesDEV CT BIOTECHNOLOGY·Filed 2014·Granted Sep 5, 2017·1 cites·15 claims
- 1663US6022721ACatalase, the gene thereof and composition comprising the same, and process for preparing catalase using genetic engineering technologyDEV CT BIOTECHNOLOGY·Filed 1998·Granted Feb 8, 2000·21 cites·19 claims
- 1762US12187806B2Anti-CD73 antibodies and use thereofDEV CT BIOTECHNOLOGY·Filed 2022·Granted Jan 7, 2025·0 cites·33 claims
- 1860US9474777B2Plant extract and the process for treating hepatic fibrosis and liver cancerDEV CT BIOTECHNOLOGY·Filed 2013·Granted Oct 25, 2016·1 cites·6 claims
- 1960US5981577Aα-methylene peperomins and halogenated derivatives thereofDEV CT BIOTECHNOLOGY·Filed 1998·Granted Nov 9, 1999·12 cites·24 claims
- 2059US5840991AAntiatherosclerosis agents for lipid-lowering and antiperoxidative activityDEV CT BIOTECHNOLOGY·Filed 1997·Granted Nov 24, 1998·8 cites·13 claims
- 2159US2025197501A1Recombinant antibody, immunoconjugate comprising the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2257US2024209095A1Anti-human pd-l1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2356US2024197780A1Chimeric antigen receptors, nucleic acids encoding the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2455US2025066793A1Anti-sense oligonucleotides and uses thereofDEV CT BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 2554US10752688B2Anti-human TIM-3 antibodies and methods of use thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Aug 25, 2020·0 cites·8 claims
- 2653US5063244AProcess for the isolation of antifungal agents (5-methoxy-7-hydroxyflavan) from dragon's blood resin and its use in agricultureDEV CT BIOTECHNOLOGY·Filed 1990·Granted Nov 5, 1991·8 cites·2 claims
- 2753US2024218337A1Fusion protein targeting pd-l1 and neutralizing gas6 and uses thereofDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2852US6110480AMethod for preparing an environmentally compatable porous material comprising beneficial nematodes and the biotic preparations produced therefromDEV CT BIOTECHNOLOGY·Filed 1997·Granted Aug 29, 2000·26 cites·20 claims
- 2952US5462863AIsolation of Hepatitis B surface antigen from transformed yeast cellsDEV CT BIOTECHNOLOGY·Filed 1994·Granted Oct 31, 1995·18 cites·26 claims
- 3051US12202899B2Anti-human PD-L1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2019·Granted Jan 21, 2025·0 cites·15 claims
- 3150US11998613B2Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2021·Granted Jun 4, 2024·0 cites·15 claims
- 3250US10561700B2Use of overground part of Hedychium coronarium Koenig in reducing blood glucose; extracts and compositions of overground part of Hedychium coronarium Koenig and their usesDEV CT BIOTECHNOLOGY·Filed 2016·Granted Feb 18, 2020·0 cites·10 claims
- 3350US9801888B2Pyrimidine compounds as mTOR and PI3K inhibitorsDEV CT BIOTECHNOLOGY·Filed 2016·Granted Oct 31, 2017·0 cites·10 claims
- 3450US5616713AProcess of preparing 2-hydroxymethyl-3,5-dimethyl-4-methoxypyridineDEV CT BIOTECHNOLOGY·Filed 1996·Granted Apr 1, 1997·5 cites·20 claims
- 3550US5360927AProcess for the preparation of monohydrated sodium phenylpyruvateDEV CT BIOTECHNOLOGY·Filed 1994·Granted Nov 1, 1994·5 cites·6 claims
- 3649US12043668B2Anti-human CSF-1R antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
- 3749US9872879B2Process for the preparation of plant extracts for treating skin disorders and enhancing healing of woundsDEV CT BIOTECHNOLOGY·Filed 2013·Granted Jan 23, 2018·0 cites·1 claims
- 3848US2025381225A1Recombinant antibodies, chimeric antigen receptors, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 3945US6015704AMutant aspartase and the preparation thereofDEV CT BIOTECHNOLOGY·Filed 1997·Granted Jan 18, 2000·9 cites·7 claims
- 4044US10138300B2Anti-VEGFR antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Nov 27, 2018·0 cites·10 claims
- 4144US5625069AProcess for preparing 2-cyano-3,5-dimethyl-4-methoxypyridineDEV CT BIOTECHNOLOGY·Filed 1996·Granted Apr 29, 1997·3 cites·20 claims
- 4244US2021015942A1Antibody protac conjugatesDEV CT BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 4343US11384150B2Antibody-drug conjugates and uses thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Jul 12, 2022·0 cites·10 claims
- 4443US10793542B2Hetroarylamine compounds for modulating the hedgehog pathway and preparing method and uses thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Oct 6, 2020·0 cites·7 claims
- 4543US10781265B2Humanized antibodies against Globo H and uses thereof in cancer treatmentsDEV CT BIOTECHNOLOGY·Filed 2018·Granted Sep 22, 2020·0 cites·13 claims
- 4643US9447193B2Methods for suppressing cancer by inhibition of TMCC3DEV CT BIOTECHNOLOGY·Filed 2014·Granted Sep 20, 2016·0 cites·7 claims
- 4742US6071913AAngiotensin II receptor antagonistic 1,2,4-triazin-5-one derivativesDEV CT BIOTECHNOLOGY·Filed 1997·Granted Jun 6, 2000·3 cites·5 claims
- 4842US5942546ASulfonyl-N-hydroxyguanidine derivativesDEV CT BIOTECHNOLOGY·Filed 1997·Granted Aug 24, 1999·3 cites·27 claims
- 4942US2018185312A1Method and composition for preventing or treating immune allergic airway diseaseDEV CT BIOTECHNOLOGY·Filed 2016·Application pending·0 cites
- 5041US11499139B2Targeted integration sites in Chinese hamster ovary cell genomeDEV CT BIOTECHNOLOGY·Filed 2017·Granted Nov 15, 2022·0 cites·25 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DEV CT BIOTECHNOLOGY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →